Peptron Gets Phase 1 Approval for Monthly Obesity Drug

Cover art for Peptron Gets Phase 1 Approval for Monthly Obesity Drug

TL;DR: Peptron received South Korea's Ministry of Food and Drug Safety approval for PT403, a once-monthly obesity treatment candidate, with first dose planned for December. Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December. Peptron received approval from South Korea's Ministry of Food and Drug Safety for PT403, a once-monthly obesity treatment candidate.

BigGo FinanceNov 19, 2026

From · · · 1m 10s

TL;DR: Peptron Gets Phase 1 Approval for Monthly Obesity Drug

Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December.

Peptron received South Korea's Ministry of Food and Drug Safety approval for PT403, a once-monthly obesity treatment candidate, with first dose planned for December. Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December. Peptron received approval from South Korea's Ministry of Food and Drug Safety for PT403, a once-monthly obesity treatment candidate.

  • Peptron Wins Phase 1 Approval
  • PT403 Uses SmartDepot Platform
  • First Dose Targeted for December
  • Trial at Chungnam National University Hospital

Read the story version — the same reporting as a swipeable deck of 6 cards.

Read the original on BigGo Finance

More news from South Korea

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on peptron and related topics.